Jump to main content
博士論文

Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax

Persistent ID (NDL)
info:ndljp/pid/13719444
Material type
博士論文
Author
颯田, 稔久
Publisher
颯田, 稔久
Publication date
2024
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
東京医科歯科大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
颯田, 稔久
Publication, Distribution, etc.
Publication Date
2024
Publication Date (W3CDTF)
2024
Alternative Title
急性骨髄性白血病に対するmTORC1/2阻害薬とvenetoclaxの相乗的治療効果
Degree grantor/type
東京医科歯科大学
Date Granted
2024-03-15
Date Granted (W3CDTF)
2024-03-15